As with ovarian cancers, miR-21 levels in endometrial cancers are on average 2-fold higher than in benign tissue [98], which is consistent with the concept that elevated miR-21 in the presence of low levels of PGRMC2 promotes migration of both ovarian and endometrial cancers. This evidence concerns the gene PGRMC2 and ovarian carcinoma.